Literature DB >> 31957638

Effects of a 12-week yoga versus a 12-week educational film intervention on symptoms of restless legs syndrome and related outcomes: an exploratory randomized controlled trial.

Kim E Innes1, Terry Kit Selfe2, Caitlin Montgomery1, Nicole Hollingshead3, Zenzi Huysmans4, Roshini Srinivasan3, Sijin Wen5, Madeleine J Hausmann3, Karen Sherman6, Maryanna Klatt3.   

Abstract

STUDY
OBJECTIVES: To assess the effects of a yoga versus educational film (EF) program on restless legs syndrome (RLS) symptoms and related outcomes in adults with RLS.
METHODS: Forty-one community-dwelling, ambulatory nonpregnant adults with moderate to severe RLS were randomized to a 12-week yoga (n = 19) or EF program (n = 22). In addition to attending classes, all participants completed practice/treatment logs. Yoga group participants were asked to practice at home 30 minutes per day on nonclass days; EF participants were instructed to record any RLS treatments used on their daily logs. Core outcomes assessed pretreatment and posttreatment were RLS symptoms and symptom severity (International RLS Study Group Scale (IRLS) and RLS ordinal scale), sleep quality, mood, perceived stress, and quality of life (QOL).
RESULTS: Thirty adults (13 yoga, 17 EF), aged 24 to 73 (mean = 50.4 ± 2.4 years), completed the 12-week study (78% female, 80.5% white). Post-intervention, both groups showed significant improvement in RLS symptoms and severity, perceived stress, mood, and QOL-mental health (P ≤ .04). Relative to the EF group, yoga participants demonstrated significantly greater reductions in RLS symptoms and symptom severity (P ≤ .01), and greater improvements in perceived stress and mood (P ≤ .04), as well as sleep quality (P = .09); RLS symptoms decreased to minimal/mild in 77% of yoga group participants, with none scoring in the severe range by week 12, versus 24% and 12%, respectively, in EF participants. In the yoga group, IRLS and RLS severity scores declined with increasing minutes of homework practice (r = .7, P = .009 and r = .6, P = .03, respectively), suggesting a possible dose-response relationship.
CONCLUSIONS: Findings of this exploratory RCT suggest that yoga may be effective in reducing RLS symptoms and symptom severity, decreasing perceived stress, and improving mood and sleep in adults with RLS. CLINICAL TRIAL REGISTRATION: Registry: Clinicaltrials.gov; Title: Yoga vs. Education for Restless Legs: a Feasibility Study; Identifier: NCT03570515; URL: https://clinicaltrials.gov/ct2/show/NCT03570515.
© 2020 American Academy of Sleep Medicine.

Entities:  

Keywords:  education; exercise therapy; mental health; mind-body; quality of life; restless legs syndrome; sleep disorders; yoga

Mesh:

Year:  2020        PMID: 31957638      PMCID: PMC7053002          DOI: 10.5664/jcsm.8134

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  83 in total

1.  Adult and geriatric normative data and validation of the profile of mood states.

Authors:  D L Nyenhuis; C Yamamoto; T Luchetta; A Terrien; A Parmentier
Journal:  J Clin Psychol       Date:  1999-01

Review 2.  Restless legs syndrome.

Authors:  Karl Ekbom; J Ulfberg
Journal:  J Intern Med       Date:  2009-11       Impact factor: 8.989

Review 3.  Yoga as an alternative and complementary approach for stress management: a systematic review.

Authors:  Manoj Sharma
Journal:  J Evid Based Complementary Altern Med       Date:  2013-09-12

4.  Loss of response during long-term treatment of restless legs syndrome: guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trials.

Authors:  D Garcia-Borreguero; R Allen; R Kohnen; H Benes; J Winkelman; B Högl; L Ferini-Strambi; M Zucconi; C Trenkwalder
Journal:  Sleep Med       Date:  2010-10       Impact factor: 3.492

Review 5.  The effects of yoga on physical functioning and health related quality of life in older adults: a systematic review and meta-analysis.

Authors:  Neela K Patel; Ann H Newstead; Robert L Ferrer
Journal:  J Altern Complement Med       Date:  2012-08-21       Impact factor: 2.579

6.  Cerebral blood flow effects of yoga training: preliminary evaluation of 4 cases.

Authors:  Debbie L Cohen; Nancy Wintering; Victoria Tolles; Raymond R Townsend; John T Farrar; Mary Lou Galantino; Andrew B Newberg
Journal:  J Altern Complement Med       Date:  2009-01       Impact factor: 2.579

7.  Complementary and alternative medicine use among adults and children: United States, 2007.

Authors:  Patricia M Barnes; Barbara Bloom; Richard L Nahin
Journal:  Natl Health Stat Report       Date:  2008-12-10

Review 8.  Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis.

Authors:  Timothy J Wilt; Roderick MacDonald; Jeannine Ouellette; Imran S Khawaja; Indulis Rutks; Mary Butler; Howard A Fink
Journal:  JAMA Intern Med       Date:  2013-04-08       Impact factor: 21.873

Review 9.  Clinical significance of RLS.

Authors:  Wayne A Hening; Richard P Allen; K Ray Chaudhuri; Magdolna Hornyak; Hochang B Lee; John Winkelman; Robert Yoakum
Journal:  Mov Disord       Date:  2007       Impact factor: 10.338

10.  Novel Exercises for Restless Legs Syndrome: A Randomized, Controlled Trial.

Authors:  Eloise G Harrison; Jennifer L Keating; Prue Morgan
Journal:  J Am Board Fam Med       Date:  2018 Sep-Oct       Impact factor: 2.657

View more
  3 in total

1.  Yoga versus educational film intervention in restless legs syndrome: extension of trial may be beneficial to patients.

Authors:  Mahadevappa Hunasikatti
Journal:  J Clin Sleep Med       Date:  2020-02-12       Impact factor: 4.062

2.  An Exploratory Randomized Controlled Trial of a 12-Week Yoga Versus Educational Film Program for the Management of Restless Legs Syndrome: Feasibility and Acceptability.

Authors:  Terry Kit Selfe; Caitlin Montgomery; Maryanna Klatt; Sijin Wen; Karen J Sherman; Kim E Innes
Journal:  J Integr Complement Med       Date:  2022-01-18

Review 3.  Restless Legs Syndrome: Contemporary Diagnosis and Treatment.

Authors:  Thomas R Gossard; Lynn Marie Trotti; Aleksandar Videnovic; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-04-20       Impact factor: 7.620

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.